Insider · CIK 0001657874

Perry Nicole D

Reports to the SEC for 1 company · CRESTWOOD, KY

sec.gov

Transactions

Companies

Filings

CIK

0001657874

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-08-02	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+1,000 sh	$3.76	+$3,760	5,847
2021-08-02	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−1,000 sh	$63.99	−$64K	4,847
2021-08-02	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−1,000 sh	—	—	6,161
2021-07-01	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+1,000 sh	$3.76	+$3,760	5,847
2021-07-01	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−1,000 sh	$64.00	−$64K	4,847
2021-07-01	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−1,000 sh	—	—	7,161
2021-06-11	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+1,000 sh	$3.20	+$3,200	5,847
2021-06-11	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−1,000 sh	$61.55	−$61.6K	4,847
2021-06-11	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−1,000 sh	—	—	34,161
2021-06-01	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+1,000 sh	$3.76	+$3,760	5,847
2021-06-01	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−1,000 sh	$56.40	−$56.4K	4,847
2021-06-01	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−1,000 sh	—	—	8,161
2021-05-03	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+1,000 sh	$3.76	+$3,760	5,847
2021-05-03	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−1,000 sh	$50.73	−$50.7K	4,847
2021-05-03	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−1,000 sh	—	—	9,161
2021-04-30	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+1,000 sh	$3.76	+$3,760	5,847
2021-04-30	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−1,000 sh	$50.00	−$50K	4,847
2021-04-30	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−1,000 sh	—	—	10,161
2021-03-01	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+2,000 sh	$3.76	+$7,520	4,347
2021-03-01	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−2,000 sh	$50.00	−$100K	2,347
2021-03-01	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−2,000 sh	—	—	11,161
2021-02-10	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Vice President - Accounting	FTax Payment	−153 sh	$47.72	−$7,301.16	2,347
2021-02-09	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+2,000 sh	$3.76	+$7,520	4,500
2021-02-09	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−2,000 sh	$50.00	−$100K	2,500
2021-02-09	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−2,000 sh	—	—	13,161
2021-01-28	APLSApellis Pharmaceuticals, Inc.A Award	Vice President - Accounting	AAward	+2,500 sh	—	—	2,500
2021-01-28	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Vice President - Accounting	AAward	+15K sh	—	—	15,000
2021-01-04	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+2,000 sh	$3.76	+$7,520	2,000
2021-01-04	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−2,000 sh	$57.24	−$114K	0
2021-01-04	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−2,000 sh	—	—	15,161
2020-12-04	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	+18K sh	$3.76	+$67.7K	18,000
2020-12-04	APLSApellis Pharmaceuticals, Inc.S Sale	Vice President - Accounting	SSale	−18K sh	$50.00	−$900K	0
2020-12-04	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Vice President - Accounting	MExercise/Conversion	−18K sh	—	—	17,161
2020-02-10	APLSApellis Pharmaceuticals, Inc.A Award	Vice President - Accounting	AAward	+2,500 sh	—	—	2,500
2020-02-10	APLSApellis Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Vice President - Accounting	AAward	+15K sh	—	—	15,000
2019-02-08	APLSApellis Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Vice President - Accounting	AAward	+22K sh	—	—	22,000
2018-02-16	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Vice President - Accounting	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Aug 34
Perry Nicole D0001127602-21-022938
SEC(opens sec.gov)
Jul 24
Perry Nicole D0001127602-21-021194
SEC(opens sec.gov)
Jun 154
Perry Nicole D0001127602-21-019902
SEC(opens sec.gov)
Jun 24
Perry Nicole D0001127602-21-018704
SEC(opens sec.gov)
May 44
Perry Nicole D0001127602-21-015186
SEC(opens sec.gov)
May 34
Perry Nicole D0001127602-21-014986
SEC(opens sec.gov)
Mar 34
Perry Nicole D0001127602-21-009099
SEC(opens sec.gov)

Companies

Apellis Pharmaceuticals, Inc.Vice President - AccountingAPLS

Address

C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A

CRESTWOOD, KY, 40014